Sanofi’s Alpha-1 Antitrypsin Deficiency (AATD) Thought Leader Liaison (TLL) is a field-based commercial role that leverages data to seamlessly identify and profile customers, coordinates HCP peer-to-peer and patient programming, as well as gathers insights across customer groups to inform commercial strategy and execution.
$146,250.00 - $211,250.00; Not specified; Not specified
Must-have
Nice-to-have
US and Puerto Rico Residents Only